Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.39 USD | -6.34% | -16.97% | -34.31% |
05-23 | Transcript : Altimmune, Inc. Presents at UBS Obesity Therapeutics Day, May-23-2024 10:00 AM | |
05-09 | Transcript : Altimmune, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.31% | 524M | |
+10.79% | 116B | |
+11.65% | 106B | |
-6.20% | 23.89B | |
-3.41% | 21.58B | |
-11.02% | 18.96B | |
-13.41% | 16.33B | |
-40.50% | 16.96B | |
+6.64% | 14.14B | |
+31.84% | 12.02B |
- Stock Market
- Equities
- ALT Stock
- News Altimmune, Inc.
- B. Riley Lowers Altimmune's Price Target to $15 From $20, Keeps Buy Rating